Short report: the effect of misoprostol on the anaemia of NSAID enteropathy

No abstract is available for this paper.

• Publication year

  1994

• Venue

  Alimentary Pharmacology and Therapeutics

• Publication date

  1994-06-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/j.1365-2036.1994.tb00298.xPMID 7918931
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Anti-inflammatory Drugs

  2020cited by this paper
• Oxygen radical scavengers are protective against indomethacin-induced intestinal ulceration in the rat.

  1995cited by this paper
• Treatment of nonsteroidal anti-inflammatory drug-induced enteropathy.

  1995cited by this paper
• Metronidazole reduces intestinal inflammation and blood loss in non-steroidal anti-inflammatory drug induced enteropathy.

  1992cited by this paper
• Gastrointestinal damage associated with the use of nonsteroidal antiinflammatory drugs.

  1992cited by this paper
• Enteroscopic diagnosis of small bowel ulceration in patients receiving non-steroidal anti-inflammatory drugs.

  1991cited by this paper
• Treatment of non-steroidal anti-inflammatory drug induced enteropathy.

  1990cited by this paper
• Iron deficiency anaemia in patients with rheumatic disease receiving non-steroidal anti-inflammatory drugs: the role of upper gastrointestinal lesions.

  1990cited by this paper
• Experimental non-steroidal anti-inflammatory drug-induced enteropathy in the rat: similarities to inflammatory bowel disease and effect of thromboxane synthetase inhibitors.

  1990cited by this paper
• NSAID‐associated gastroduodenal damage: does famotidine protection extend into the mid‐and distal duodenum?

  1990cited by this paper
• The changing gastrointestinal side effect profile of non-steroidal anti-inflammatory drugs. A new approach for the prevention of a new problem.

  1989cited by this paper
• Misoprostol reduces indomethacin-induced changes in human small intestinal permeability

  1989cited by this paper
• Nonsteroidal antiinflammatory drug-induced intestinal inflammation in humans.

  1987cited by this paper
• Mechanism of exacerbation of rheumatoid synovitis by total-dose iron-dextran infusion: in-vivo demonstration of iron-promoted oxidant stress.

  1987cited by this paper
• Role of misoprostol in reducing aspirin-induced gastrointestinal blood loss in arthritic patients.

  1987cited by this paper

• Current knowledge on non-steroidal anti-inflammatory drug-induced small-bowel damage: a comprehensive review

  2019cites this paper
• Effectiveness of acid suppressants and other mucoprotective agents in reducing the risk of occult gastrointestinal bleeding in nonsteroidal anti-inflammatory drug users

  2019cites this paper
• Potential Strategies in the Prevention of Nonsteroidal Anti-inflammatory Drugs-Associated Adverse Effects in the Lower Gastrointestinal Tract

  2019cites this paper
• Misoprostol for small bowel ulcers in patients with obscure bleeding taking aspirin and non-steroidal anti-inflammatory drugs (MASTERS): a randomised, double-blind, placebo-controlled, phase 3 trial.

  2018cites this paper
• Human Intestinal Barrier Function in Health and Disease

  2016cites this paper
• Environmental and NSAID-Enteropathy: Dysbiosis as a Common Factor

  2014cites this paper
• Dipeptidyl Peptidase IV Inhibition Prevents the Formation and Promotes the Healing of Indomethacin-Induced Intestinal Ulcers in Rats

  2014cites this paper
• Mechanisms, prevention and clinical implications of nonsteroidal anti-inflammatory drug-enteropathy.

  2013cites this paper
• Ulcerating and stenosing enteropathy treated with misoprostol: a case report with analysis of prostaglandin metabolism

  2012cites this paper
• [Enteropathy induced by nonsteroid anti-inflammatory drugs: pathogenesis, diagnosis, treatment].

  2012cites this paper
• Double lumen appearance of the cecum presumably caused by acetyl salicylic acid- induced ileocecal valve ulcers and deformation

  2011cites this paper
• Nonsteroidal antiinflammatory drug-related injury to the gastrointestinal tract: clinical picture, pathogenesis, and prevention.

  2010cites this paper
• [Guidelines of prevention and treatment for NSAID-related peptic ulcers].

  2009cites this paper
• Nonsteroidal Antiinflammatory Drugs and Cyclooxygenase Inhibition in the Gastrointestinal Tract: A Trip From Peptic Ulcer to Colon Cancer

  2009cites this paper
• Nonsteroidal anti-inflammatory drugs and lower gastrointestinal complications.

  2009cites this paper
• HSP70 Confers Protection against Indomethacin-Induced Lesions of the Small Intestine

  2009cites this paper
• Present status and strategy of NSAIDs-induced small bowel injury

  2009cites this paper
• Intestinal permeability in the pathogenesis of NSAID-induced enteropathy

  2009cites this paper
• Preventing nonsteroidal anti-inflammatory drug-induced small-bowel injury: the saga continues.

  2009cites this paper
• Faecal blood loss with aspirin, nonsteroidal anti-inflammatory drugs and cyclo-oxygenase-2 selective inhibitors: systematic review of randomized trials using autologous chromium-labelled erythrocytes

  2008cites this paper
• Less small-bowel injury with lumiracoxib compared with naproxen plus omeprazole.

  2008cites this paper
• Small bowel injury by low-dose enteric-coated aspirin and treatment with misoprostol: a pilot study.

  2008cites this paper
• ess Small-Bowel Injury With Lumiracoxib Compared With Naproxen Plus meprazole

  2008cites this paper
• Lower gastrointestinal events in a double-blind trial of the cyclo-oxygenase-2 selective inhibitor etoricoxib and the traditional nonsteroidal anti-inflammatory drug diclofenac.

  2008cites this paper
• NSAID-induced intestinal damage: are luminal bacteria the therapeutic target?

  2008cites this paper
• Small bowel enteropathy associated with chronic low-dose aspirin therapy.

  2007cites this paper
• Response to: Appropriate choice of proton pump inhibitor therapy in the prevention and management of NSAID‐related gastrointestinal damage

  2006cites this paper
• Is non-steroidal anti-inflammaory drug (NSAID) enteropathy clinically more important than NSAID gastropathy?

  2006cites this paper
• Adverse reactions and their mechanisms from nimesulide

  2005cites this paper
• Impact of COX-2 inhibitors in common clinical practice a gastroenterologist's perspective.

  2005cites this paper
• VIDEO CAPSULE ENDOSCOPY TO PROSPECTIVELY ASSESS SMALL BOWEL INJURY WITH CELECOXIB, NAPROXEN PLUS OMEPRAZOLE, AND PLACEBO

  2005cites this paper
• Clinical and endoscopic features of non-steroidal anti-inflammatory drug-induced colorectal ulcerations.

  2005cites this paper
• Effect of nonsteroidal anti-inflammatory drugs on the gastrointestinal tract: diagnosis by wireless capsule endoscopy.

  2004cites this paper
• Is the use of COX-2 inhibitors in gastroenterology cost-effective?

  2004cites this paper
• [Enteropathy induced by nonsteroid anti-inflammatory drugs].

  2004cites this paper
• Serious lower gastrointestinal clinical events with nonselective NSAID or coxib use.

  2003cites this paper
• Fecal calprotectin as an index of intestinal inflammation.

  2001cites this paper
• NSAID‐induced small bowel perforation

  2001cites this paper
• Misoprostol Therapeutics Revisited

  2001cites this paper
• Clinical implications of prostaglandin inhibition in the small bowel.

  2001cites this paper
• Detection and prevention of NSAID-induced enteropathy.

  2000cites this paper
• Die chronisch medikamentös-toxische Schleimhautschädigung mit Dünndarmperforation

  2000cites this paper
• The small bowel as a source of gastrointestinal blood loss

  1999cites this paper
• Small bowel diseases in the elderly.

  1999cites this paper
• High prevalence of NSAID enteropathy as shown by a simple faecal test

  1999cites this paper
• Review article: the diagnosis and treatment of haematinic deficiency in gastrointestinal disease

  1998cites this paper
• Diclofenac/misoprostol: novel findings and their clinical potential.

  1998cites this paper
• Gastrointestinal side effects of nonsteroidal anti-inflammatory drugs.

  1998cites this paper
• Ulkusrisiko und-prophylaxe bei der Therapie mit nichtsteroidalen Antirheumatika

  1997cites this paper
• [Risk of ulcer and its prophylaxis in therapy with non-steroidal antirheumatic drugs].

  1997cites this paper
• Upper gastrointestinal tract.

  1995cites this paper
• Upper gastrointestinal tract: In reply

  1995cites this paper
• Studies on the gastric tolerability of the new non-steroidal anti-inflammatory drug amtolmetin guacyl.

  1995cites this paper
• Misoprostol/NSAID Fixed Combinations

  1995cites this paper
• Upper gastrointestinal tract

  1995cites this paper